Anavex Life Sciences Corp (AVXL)

[AlchemicalVoyager13]

Mayo: While you do a high level of research your projections well into the high hundreds of dollars per share are fantasy. You do not consider competition for example, and I am meaning other potential oral treatments from the likes of Annovis and Cognition Therapeutics, which is for Tau 217 really. Furthermore, to consider JnJ when they have a huge product line that is non-drug for P/E is not reasonable. Furthermore, companies that are established with predicable earnings carry a lot more weight than a one trick pony. Your numbers are ridiculous, sorry, but they are. IF we get approved it will be for WT only in all likelihood and conditional. CGTX has a reasonable chance of surpassing our market cap inside two years by leaps and bounds. You may know pharmacology but your business acumen is lacking.